A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Clinical trial NCT06375733 · RECRUITING
Trial details
- NCT number
- NCT06375733
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2026-12-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.